Stories by Damian Garde

Similarly effective drugs in the pipeline will also be gauged against their enormous price tags

The alleged incident occurred in October

Does the data in a recent clinical trial support the idea that removing amyloid clumps can improve mental functioning?

The surprising results have buoyed hopes for treatment

Since criminal charges were filed, these may be the most pressing issues

Clinical trial patients had two fewer headaches a month compared with those who received a placebo 

This gene therapy for vision loss will initially cost $850,000

The pricey therapy is designed for adults with advanced lymphoma

The leukemia treatment approval opens up a new front for gene therapies in the U.S.

The experimental treatment will now face review by the agency

Scientists from all over the country are calling for an end to a immigration ban that could potentially affect thousands of scientists working in the U.S.

The result could be a major setback for the strategy of attacking amyloid plaques 

Priorities at the NIH, the BRAIN Initiative, drug price controls and more initiatives could shift in major ways

The gene therapy could save kids with severe combined immune deficiency

Standard chemo blamed, experimental immune therapy cleared

An immune system booster called CAR-T appears to cause lethal brain injury

As opioid addiction soars, biotech companies eye a genetic mutation in people who feel no pain